biochips
MDx Platform Firm InSilixa Completes $13M Financing Round
NEW YORK (GenomeWeb) – New molecular diagnostics platform firm InSilixa has completed a $13 million private financing round.
Fluidigm of South San Francisco, Calif., has received US Patent No.
By Justin Petrone
The Singapore Institute of Manufacturing Technology has established a new resource to help companies develop microfluidic devices, including biochips.
Companies developing array- or biochip-based molecular diagnostics received a shot in the arm earlier this month under the Internal Revenue Service's $1 billion Qualifying Therapeutic Discovery Project program.
While the majority of the new funding will support genome-wide association studies, also benefiting from the federal stimulus package are research projects focused on copy number-variation analysis, gene expression, and bioinformatics.
Mar 10, 2009
Mar 10, 2009
New Product Watch: Mar 10, 2009
Premium
Feb 17, 2009
Feb 12, 2009